Futura Medical’s half-year results turn off investors
AIM-listed Futura Medical watched its share price drop by 12.94% as its net loss for the six months ended 30th June more than doubled.
AIM-listed Futura Medical watched its share price drop by 12.94% as its net loss for the six months ended 30th June more than doubled.
The price of shares in building materials producer Epwin jumped 8.44% as like-for-like revenues for the first half were up against tough comparatives.
Shares in FTSE 250 housebuilder Galliford Try rose by 3.24% despite group revenues dropping for the year ended 30th June.
Robert Stephens discusses why Bunzl’s competitive advantage and growth prospects could lead to a higher stock price.
Solgold, my best tip – up from under 3p in 2015 to a 45p peak in 2017 – has been up and down ever since, like the proverbials in Klondike mining towns.
The price of shares in FTSE 100 retailer JD Sports Fashion jumped 7.94% after revenues for the half year to 3rd August climbed by 47%.
FTSE 250 construction firm Bovis Homes posted record profits before tax during the six months ended 30th June, but shares in the company dropped by 3.12%.
The price of shares in AIM-listed mobile payments firm Boku rose by 5.39% after it reported a 39% increase in revenues for the six months ended 30th June.
With AIM dividends having tripled since 2012, James Faulkner reveals how investors can gain exposure to this exciting income stream.
Polar Capital is a company always seeking growth, value and relative safety but still enjoying net inflows of fresh funds, writes Mark Watson-Mitchell.